Molecular diagnostic tools continue to drive biomedical research. Technological advances from next-generation sequencing, microarrays, quantitative PCR, microfluidics and POC enable speed, enhance sensitivity, and reduce costs. Cancer and infectious disease two diagnostic applications with widespread clinical impact are the main emphasis for Molecular Diagnostics Europe.